EBITDA Growth
14.74%
Quarterly · Period ending:
EMR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported14.74%period ending
Latest reported14.74%period ending
EMR Quarterly EBITDA YoY % (-6.72% → 14.74%)
Year-over-year change
High-resolution chart · PNG
EMR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 14.7377% | |
| 15.7416% | |
| 3.3058% | |
| 11.487% | |
| 29.4181% | |
| -10.2857% | |
| 77.6799% | |
| 3.4174% | |
| -14.7842% | |
| 25.8993% | |
| -9.2% | |
| -6.1115% | |
| 64.7504% | |
| 32.381% | |
| -35.4561% | |
| 16.9794% | |
| -37.5236% | |
| -27.5148% | |
| 36.8669% | |
| 8.5354% | |
| 47.7654% | |
| 7.6433% | |
| 25.7778% | |
| -6.7812% | |
| -29.8039% | |
| 0.8565% | |
| -19.7384% | |
| 7.5875% | |
| 3.4483% | |
| 3.8932% | |
| 13.8024% | |
| 12.1047% | |
| 18.6522% | |
| 19.0728% | |
| 12.1396% | |
| 85.6275% | |
| -2.1201% | |
| 0.9358% | |
| 4.4374% | |
| -60.3849% | |
| -18.8337% | |
| -59.7417% | |
| -38.439% | |
| 15.7846% | |
| -21.2942% | |
| 72.3562% | |
| 12.2673% | |
| -25.6215% | |
| 73.0469% | |
| -1.6423% | |
| -2.5614% | |
| 69.1589% | |
| -45.9916% | |
| 1.5755% | |
| 14.4078% | |
| -36.7799% | |
| 12.1451% | |
| -2.8803% | |
| -17.8536% | |
| 23.5401% | |
| 10.5493% | |
| 26.25% | |
| 18.5493% | |
| 17.9763% | |
| 43.0175% | |
| 11.5336% | |
| -6.5556% | |
| -30.0978% | |
| -35.9425% | |
| -31.2119% | |
| -9.7292% | |
| 13.8817% | |
| 14.652% | |
| 16.9215% | |
| 15.3935% | |
| 14.8622% | |
| 13.0435% | |
| 11.2245% | |
| 10.2041% | |
| 18.1395% | |
| 16.5259% | |
| 17.9144% | |
| 15.805% | |
| 13.9073% | |
| 9.8013% | |
| 8.7209% | |
| 8.6677% | |
| 12.855% | |
| 14.7416% | |
| 11.5073% | |
| 12.6582% | |
| 10.5785% | |
| 0.5348% | |
| 2.4406% | |
| 0% | |
| 510.7264% | |
| -19.929% | |
| -28.4339% | |
| -29.59% | |
| -117.2523% |